Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
The 2025 Payers Guide to GLP-1 Drugs Download this guide, which shares the latest on the GLP-1 drug landscape and how payers can address the evolving clinical and financial impacts
Pharmacological weight management with GLP-1 agonists is consequently an attractive option for managing obesity in children
DISCUSSION This review examines how GLP-1 receptor agonists have various effects on neurochemical and physiologic pathways in the brain to mitigate alcohol-seeking behavior
Photo by Innerbody Research In recent years, the peptide space has seen a significant uptick in drug discovery, clinical research, and therapeutic applications.25 Even so, these treatments remain unfamiliar to a lot of prospective patients, who arent exactly sure what peptides are or how they work
This data currently includes diabetes-indicated GLP-1s like Ozempic and Mounjaro, given that patients may have dual diagnoses of obesity/type 2 diabetes or some prior obesity diagnosis (during the 10-year analysis period)
